Spots Global Cancer Trial Database for Radiation Omission in Patients With HER2 Overexpressing Tumors With Pathologic Complete Response
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Radiation Omission in Patients With HER2 Overexpressing Tumors With Pathologic Complete Response
Official Title: Radiation Omission in Patients With HER2 Overexpressing Tumors With Pathologic
Study ID: NCT05371860
Interventions
Study Description
Brief Summary: The purpose of this study is to evaluate the feasibility, based on recruitment rate over a 3-year period, of enrolling patients for the omission of post-operative breast radiation following breast conserving surgery and sentinel node biopsy or axillary lymph node dissection in women with HER2+ breast cancer who achieve pathologic complete response.
Detailed Description:
Eligibility
Minimum Age: 40 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: FEMALE
Healthy Volunteers: No
Locations
Cedars-Sinai Medical Center, Los Angeles, California, United States
Contact Details
Name: Armando Giuliano, MD, FACS, FRCSEd
Affiliation: Cedars-Sinai Medical Center
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
